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Summary
The AP-2 family of transcription factors consists of five different proteins in humans and mice: AP-2 ,
AP-2 , AP-2 , AP-2  and AP-2 . Frogs and fish have known orthologs of some but not all of
these proteins, and homologs of the family are also found in protochordates, insects and
nematodes. The proteins have a characteristic helix-span-helix motif at the carboxyl terminus,
which, together with a central basic region, mediates dimerization and DNA binding. The amino
terminus contains the transactivation domain. AP-2 proteins are first expressed in primitive
ectoderm of invertebrates and vertebrates; in vertebrates, they are also expressed in the
emerging neural-crest cells, and AP-2 -/- animals have impairments in neural-crest-derived facial
structures. AP-2  is indispensable for kidney development and AP-2   is necessary for the
formation of trophectoderm cells shortly after implantation; AP-2  and AP-2  levels are elevated
in human mammary carcinoma and seminoma. The general functions of the family appear to be
the cell-type-specific stimulation of proliferation and the suppression of terminal differentiation
during embryonic development. 
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Gene organization and evolutionary history 
The AP-2 family of transcription factors (Ensembl Family
ENSF00000001105) consists in humans and mice of five
members, AP-2 , AP-2 , AP-2 , AP-2  and AP-2 ; frogs and
fish have some of these proteins, and homologs are also
known in invertebrates. The chromosomal locations and
accession numbers of the family are given in Tables 1 and 2,
respectively. All mammalian AP-2 proteins except AP-2  are
encoded by seven exons and share a characteristic domain
structure (reviewed in [1]; for AP-2  see [2] and for AP-2 
see [3,4]). Orthologs show a similarity between 60 and 99%
at the amino-acid level, whereas paralogs show a similarity
between 56 and 78%.
Analysis of the phylogenetic tree (Figure 1) reveals that the
vertebrate AP-2 proteins are grouped together and are
divided into five groups. The single Xenopus AP-2 is most
closely related to mammalian AP-2  proteins. As the genes
AP-2  and  AP-2  are found on the same chromosome in
chickens, rodents and humans (Table 1), it is likely that they
are the result of an internal duplication. According to the
phylogenetic tree, AP-2  genes appear to have separated
from the rest of the family early in the vertebrate clade and
to have evolved separately (Figure 1). A BLAST search of the
puffer fish Fugu rubripes fourth genome assembly database
[5] suggests that there are orthologs of AP-2 , AP-2 , AP-2 
and AP-2  but not AP-2  genes in bony fish, although only
orthologs of AP-2  and AP-2  have been found in zebrafish.
In the genome of the protochordate Ciona intestinalis a
single AP-2 gene has been predicted; the phylogenetic tree
shows that the protein evolved before the split of the AP-2 ,
AP-2 , AP-2  and AP-2  proteins, with the highest sequence
similarity with the AP-2   group, suggesting that AP-2 
might be most similar to the ancestor of AP-2 proteins. This
hypothesis is further supported by the conserved epithelialexpression patterns of murine AP-2  [6], Xenopus AP-2 [7]
and the amphioxus and lamprey AP-2 [8] genes. As
expected, the two Caenorhabditis elegans and the single
Drosophila melanogaster AP-2 proteins show the weakest
phylogenetic relationship with vertebrate and protochor-
date AP-2 transcription factors; they form an outgroup to
the other AP-2 family members (Figure 1). Given that no
AP-2 gene has been identified in yeast, the family probably
originated late in evolution and expanded considerably in
the vertebrates.
Characteristic structural features 
All AP-2 proteins share a highly conserved helix-span-helix
dimerization motif at the carboxyl terminus, followed by a
central basic region and a less conserved domain rich in
proline and glutamine at the amino terminus (Figure 2). The
proteins are able to form hetero- as well as homodimers. The
helix-span-helix motif together with the basic region medi-
ates DNA binding [9,10], and the proline- and glutamine-
rich region is responsible for transactivation. AP-2 has been
shown to bind to the palindromic consensus sequence
5 -GCCN3GGC-3 , found in various cellular and viral
enhancers (reviewed in [1]); a binding-site selection assay
in vitro  also revealed the additional binding motifs
5 -GCCN3GGC-3 , 5 -GCCN4GGC-3  and 5 -GCCN3/4GGG-3 
[11]. Other binding sites differing from these sequence
motifs, for example, the SV40 enhancer element
5 -CCCCAGGC-3  [12], indicate that AP-2 proteins may bind
to a range of G/C-rich elements with variable affinities.
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Table 1
Chromosomal locations of AP-2 genes from selected species
AP-2  AP-2  AP-2  AP-2  AP-2  Other AP-2 genes*
H. sapiens 6p24 6p12 20q13.2 6p12.1 1p34.3
P. troglodytes 6p22.3 6p12 21 - -
M. musculus 13 A5-B1 1 A2-A4 2 H3-H4 1 A3 4 D2.2
R. norvegicus 17p12 9q13 3q42 9q13 5q36
G. gallus 23 - 3 -
X. tropicalis scaffold_278 - - - -
D. rerio 24 20 - - -
C. elegans II
D. melanogaster 3L
*The AP-2 genes of C. elegans and D. melanogaster are not orthologous to any of the five mammalian genes. Data taken from the database entries for the
accession numbers given in Table 2. No information on mapping is available for the C. intestinalis AP-2 gene.
Table 2
Accession numbers for AP-2 proteins from selected species
AP-2  AP-2  AP-2  AP-2  AP-2  Other AP-2 proteins*
H. sapiens NP_003211 NP_003212 NP_003213 NP_758438 NP_848643
P. troglodytes - XP_518532 XP_526337 - -
M. musculus NP_035677 NP_033360 NP_033361 NP_694794 NP_945198
R. norvegicus XP_225238 XP_217356 NP_958823 XP_236975 XP_233526
G. gallus NP_990425 NP_990226 - XP_426224 -
X. tropicalis AAD53289 - - - -
X. laevis AAA49972 - - - -
D. rerio NP_789829 NP_001019836 - - -
C. elegans NP_4951819
D. melanogaster NP_730664
C. intestinalis BAE06307 and BAE06308
*The AP-2 genes of C. elegans, D. melanogaster and C. intestinalis are not orthologous to any of the five mammalian genes.c
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Figure 1
Phylogenetic tree of the AP-2 family. Amino-acid sequence alignments were performed using ClustalW implemented in Sequence Data Explorer of the
MEGA3 software [67]. The phylogenetic tree was created using the neighbor-joining method (gaps setting: pairwise deletion; distance method: number of
differences). Numbers at selected nodes indicate the percentage frequencies of branch association on the basis of 1,000 bootstrap repetitions. The scale
bar indicates the number of residue changes. Asterisks indicate predicted proteins; brackets denote subfamilies in vertebrates. Species: Caenorhabditis
elegans (nematode); Ciona intestinalis (sea squirt); Drosophila melanogaster (fruit fly); Danio rerio (zebrafish); Gallus gallus (chicken); Homo sapiens (human);
Mus musculus (mouse); Pan troglodytes (chimpanzee); Rattus norvegicus (rat); Xenopus laevis and Xenopus tropicalis (frog). 
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99Target genes with AP-2-binding sites in their promoter
sequences are involved in biological processes such as cell
growth and differentiation and include, for example, those
encoding insulin-like growth factor binding protein 5 (IGF-
BP5) with the binding site 5 -GCCAGGGGC-3  [13], prothy-
mosin-  (5 -GCCGGTGGGC-3 ) [14] and the estrogen
receptor (5 -GCCTGCGGGG-3 ) [15]. 
Most AP-2 proteins have a PY motif (XPPXY) and other
highly conserved critical residues in the transactivation
domain; by contrast, the PY motif is missing in AP-2  but
the amino- and carboxy-terminal ends of the core sequence
of the transactivation domain are still conserved. In addi-
tion, the binding affinity of AP-2  to conserved AP-2-
binding sites is much lower than that of other AP-2 proteins
[2]. This suggests that AP-2  might transactivate genes in
vivo by a different mechanism from that used by other AP-2
proteins, probably through interactions with a novel group
of coactivators and through a different affinity for AP-2-
binding sites. Alternatively, AP-2  might act as a negative
regulator, inhibiting or modulating the transactivation capa-
bility or DNA-binding affinity of the other AP-2 family
members. The crystal structure of the AP-2 proteins has not
yet been solved.
Localization and function 
AP-2 transcription factors are localized predominantly in the
nucleus, where they bind to target sequences and regulate
transcription of target genes. AP-2 proteins have also been
shown to interfere with other signal transduction pathways;
for example, it has been proposed that they modulate the
pathway downstream of the developmental signaling molecule
Wnt by associating with the Adenomatous polyposis coli
(APC) tumor suppressor protein in the nucleus [16].
The activity of AP-2 proteins can be controlled at multiple
levels: their transactivation potential, their DNA binding,
their subcellular localization [17-19] and their degradation
[20,21] can all be modified. Mechanisms of regulation
include post-translational modifications, such as protein
kinase A-mediated phosphorylation [22,23], sumoylation
[24] and redox regulation [25,26], as well as physical inter-
action with various proteins (see Table 3 for a comprehen-
sive list). Interacting proteins either modulate the activity of
AP-2 proteins or are influenced in their function by binding
to AP-2 proteins.
The tissue distribution and developmental functions of AP-2
transcription factors have been studied extensively in several
species. Drosophila AP-2 (dAP-2) is expressed in the maxil-
lary segment and neural structures during embryogenesis,
and in the central nervous system (CNS) and the leg, anten-
nal and labial imaginal disks during larval development
[27,28]. Mutation of the dAP-2 gene leads to defects in pro-
boscis development and leg-joint formation [29,30].
The multiple overlapping and diverging expression patterns
of AP-2 family proteins suggest that, following the expansion
of the family during vertebrate evolution, redundant and
non-redundant functions of the individual AP-2 family
members evolved. Although the single AP-2 protein in the
cephalochordate amphioxus is expressed mainly in non-
neuronal ectoderm, in the lamprey, a primitive vertebrate,
AP-2 has co-opted a second expression domain, the neural
crest [8]. The single AP-2 homolog described so far in
Xenopus is expressed in the epidermis and neural crest and
has been shown to be critical for the development of these
structures [7,31-33]. In zebrafish, the two AP-2 family
members,  tfap2a and  tfap2b [34], are coexpressed in the
neural tube, the ectoderm and the pronephric ducts of the
developing kidney, but only tfap2a is expressed in neural
crest cells [35,36]. Positional cloning revealed that the
zebrafish point mutants named mont blanc [35] and lockjaw
[36] encode tfap2a; the mutant animals display impaired
development of neural-crest derivatives, such as the facial
skeleton, the peripheral nervous system and pigment cells
[37,38]. It is also interesting to note that AP-2 proteins are
expressed in the primitive ectoderm of both invertebrates
and vertebrates, suggesting an evolutionarily conserved role
for the family in the formation of this tissue. 
In mice, three of the five AP-2 family members (AP-2 , AP-
2  and  AP-2 ) are coexpressed in neural-crest cells, the
peripheral nervous system, facial and limb mesenchyme,
various epithelia of the developing embryo and the extra-
embryonic trophectoderm [2,39-41]. AP-2  expression is
restricted mainly to the developing heart, CNS and retina
[39], whereas AP-2  expression is detected in cells of the
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Figure 2
A schematic representation of the protein structure of an AP-2  dimer,
showing the proline- and glutamine (P/Q)-rich transactivation domain (89
amino acids, red), the PY motif within this domain (5 amino acids, green),
the basic domain (20 amino acids, yellow) and the helix-span-helix motif
(131 amino acids, blue). The helix-span-helix motif is responsible for
dimerization of the proteins and mediates DNA binding together with the
basic domain. Modified from SwissProt, ID: P34056 [68].
Transactivation
H2N
H2N
PY COOH
COOH
Dimerization
DNA binding
Basic
domain
Helix-span-helix
motif
P/Q-rich
domainolfactory bulb [3,4]. Despite the overlapping expression
patterns of AP-2 , AP-2  and AP-2 , disruption of these AP-2
genes reveals non-redundant roles during development.
Mutation of AP-2  predominantly affects the cranial neural
crest and the limb mesenchyme, leading to disturbances of
facial and limb development in a manner reminiscent of the
defects described in dAP2 mutant flies [42,43]. AP-2  and
AP-2 , on the other hand, are essential for kidney develop-
ment [44,45] or placentation of the embryo [46,47],
respectively. In humans, mutations generating a dominant
negative allele of AP-2  have been shown to be the cause of
Char syndrome (Online Mendelian Inheritance in Man
(OMIM) ID 169100 [48]); the hallmarks of this syndrome
are patent ductus arteriosus (abnormal persistence of a
normal fetal heart structure after birth) with facial dysmor-
phism and abnormal fifth digits [49,50]. 
Comparing all mutant phenotypes, it can be seen that loss of
AP-2 transcription factor activity generally impairs prolifer-
ation and induces premature differentiation and/or apopto-
sis in various cell types during development. This conclusion
is further substantiated by results from a screen for AP-2 
target genes [51] and supported by gain-of-function studies
in Xenopus and mice [31,52,53]. As uncontrolled prolifera-
tion leads to malignancies, AP-2 transcription factors are not
only implicated in normal development, but also seem to be
involved in cellular neoplasia, and enhanced AP-2 levels
have been reported in various types of cancer [19,54-60]. In
a murine breast-cancer model, tumor progression is
enhanced after transgenic overexpression of AP-2  [55].
Thus, AP-2 proteins can be viewed as gatekeepers control-
ling the balance between proliferation and differentiation
during embryogenesis. 
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Table 3
Proteins that physically interact with AP-2 transcription factors
Domain of AP-2 
Protein Description proteins that interacts* Function of interaction Reference
APC Adenomatous polyposis coli  Basic region Inhibition of  -catenin/TCF/LEF-dependent transcription [16]
tumor suppressor
CITED2 Coactivator DD Transcriptional activation [69] 
CITED4 Coactivator n.d. Transcriptional activation [70]
CDP CCAAT displacement protein DBD, DD Repression of the hamster histone H3.2 promoter [71]
DEK Oncoprotein, chromatin remodeling n.d. Transcriptional activation [72]
E1A Transforming protein of adenovirus DBD, DD Repression of AP-2 target genes [73]
c-Myc Onco-protein Carboxyl terminus Impairment of Myc/Max DNA-binding and transactivation [14]
PARP PolyADP-ribose polymerase Carboxyl terminus Transcriptional activation [74]
PAX-6 Transcription factor n.d. Stimulation of gelatinase B activation [75]
PC4 Coactivator Transcriptional activation [24]
P300/CBP Coactivator Amino terminus Transcriptional activation [69]
p53 Tumor suppressor n.d. Augmentation of p53-dependent transcription  [76]
RAP74 Subunit of transcription factor TFIIF Central region  Unknown [74]
containing DBD
Rb Retinoblastoma tumor suppressor Amino terminus† Repression of the hamster histone H3.2 promoter;  [77,78]
transcriptional activation of the E-cadherin gene
SP1 Transcription factor Basic region Transcriptional activation of the ovine CYP11A1 gene [79]
SV40T Transforming protein of SV40 virus n.d. Blocks DNA binding of AP-2 protein [12]
UBC9 E2-conjugating enzyme DBD, DD Sumoylation  [80]
WWOX Tumor suppressor Amino terminus  Cytoplasmic localization PPPY motif  [17]
PY motif
YB-1 Transcription factor n.d. Stimulation of gelatinase A transcription [81]
YY1 Transcription factor DBD, DD Stimulation of the hamster histone H3.2 promoter [82]
*Abbreviations: DBD, DNA-binding domain; DD, dimerization domain; n.d., not determined. †It is currently not entirely clear whether Rb binds AP-2
only via the amino terminus [78], or whether the DNA-binding domain is also necessary [77].Frontiers 
The lethal phenotypes of the AP-2 mutants generated so far
have precluded an analysis of the roles of AP-2 transcription
factors in adult tissues. We and others are currently exploit-
ing the power of conditional mouse mutants to overcome
these restrictions [61-63]. Such approaches will not only
shed light on normal AP-2 functions but will probably also
lead to unique insights into human disorders.
Complementary approaches currently include the identifica-
tion of AP-2 target genes; this might give a better under-
standing of developmental disturbances and pave the way to
novel treatment options [51,64]. At the molecular level, one
major challenge will be the identification of specific AP-2
homo- or hetero-dimeric complexes bound to a particular
promoter and the identification of the specific properties of
each complex with respect to gene regulation. Also, the sig-
naling pathways responsible for induction of AP-2 genes are
currently under investigation. A cross-species comparison of
the various AP-2 promoters may give insights into the evolu-
tion of tissue specificity and help to determine important
enhancer elements. Moreover, given that CpG islands are
present in AP-2 promoters, epigenetic regulation such as
DNA methylation also needs to be considered. 
AP-2 transcription factors are currently being studied exten-
sively in human cancer, and they may be of diagnostic value,
as has been demonstrated for mammary or testicular carci-
noma [19,54,56,65,66]. It is tempting to speculate that AP-2
transcription factors might not only be molecular markers
for certain types of cancer, but could also be causally
involved in their etiologies and would therefore represent a
potential target for therapeutic intervention.
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